These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 29538413)

  • 1. Functional autoantibodies in patients with different forms of dementia.
    Wallukat G; Prüss H; Müller J; Schimke I
    PLoS One; 2018; 13(3):e0192778. PubMed ID: 29538413
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aptamer BC007 for neutralization of pathogenic autoantibodies directed against G-protein coupled receptors: A vision of future treatment of patients with cardiomyopathies and positivity for those autoantibodies.
    Wallukat G; Müller J; Haberland A; Berg S; Schulz A; Freyse EJ; Vetter R; Salzsieder E; Kreutz R; Schimke I
    Atherosclerosis; 2016 Jan; 244():44-7. PubMed ID: 26584137
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Autoantibodies Directed Against the Endothelin A Receptor in Patients With Benign Prostatic Hyperplasia.
    Wallukat G; Jandrig B; Kunze R; Wendler JJ; Müller J; Schostak M; Schimke I
    Prostate; 2017 Apr; 77(5):458-465. PubMed ID: 27882567
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiomyopathy - An approach to the autoimmune background.
    Becker NP; Müller J; Göttel P; Wallukat G; Schimke I
    Autoimmun Rev; 2017 Mar; 16(3):269-286. PubMed ID: 28163240
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Agonistic autoantibodies directed against G-protein-coupled receptors and their relationship to cardiovascular diseases.
    Wallukat G; Schimke I
    Semin Immunopathol; 2014 May; 36(3):351-63. PubMed ID: 24777744
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Aptamer neutralization of beta1-adrenoceptor autoantibodies isolated from patients with cardiomyopathies.
    Haberland A; Wallukat G; Dahmen C; Kage A; Schimke I
    Circ Res; 2011 Oct; 109(9):986-92. PubMed ID: 21868696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence and Determinants of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients Screened Positive for Dementia: Results from the Population-Based DelpHi-Study.
    Thyrian JR; Hertel J; Schulze LN; Dörr M; Prüss H; Hempel P; Bimmler M; Kunze R; Grabe HJ; Teipel S; Hoffmann W
    J Alzheimers Dis; 2018; 64(4):1091-1097. PubMed ID: 30010118
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies directed against α1-adrenergic receptor and endothelin receptor A in patients with prostate cancer.
    Wallukat G; Jandrig B; Becker NP; Wendler JJ; Göttel P; Müller J; Schostak M; Schimke I
    Auto Immun Highlights; 2020 Sep; 11(1):13. PubMed ID: 32977857
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Agonistic autoantibodies to the α(1) -adrenergic receptor and the β(2) -adrenergic receptor in Alzheimer's and vascular dementia.
    Karczewski P; Hempel P; Kunze R; Bimmler M
    Scand J Immunol; 2012 May; 75(5):524-30. PubMed ID: 22260197
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The first aptamer-apheresis column specifically for clearing blood of β1-receptor autoantibodies.
    Wallukat G; Haberland A; Berg S; Schulz A; Freyse EJ; Dahmen C; Kage A; Dandel M; Vetter R; Salzsieder E; Kreutz R; Schimke I
    Circ J; 2012; 76(10):2449-55. PubMed ID: 22850243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional autoantibody diseases: Basics and treatment related to cardiomyopathies.
    Becker NP; Goettel P; Mueller J; Wallukat G; Schimke I
    Front Biosci (Landmark Ed); 2019 Jan; 24(1):48-95. PubMed ID: 30468647
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long COVID: Association of Functional Autoantibodies against G-Protein-Coupled Receptors with an Impaired Retinal Microcirculation.
    Szewczykowski C; Mardin C; Lucio M; Wallukat G; Hoffmanns J; Schröder T; Raith F; Rogge L; Heltmann F; Moritz M; Beitlich L; Schottenhamml J; Herrmann M; Harrer T; Ganslmayer M; Kruse FE; Kräter M; Guck J; Lämmer R; Zenkel M; Gießl A; Hohberger B
    Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35806214
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.
    Müller FS; Aherrahrou Z; Grasshoff H; Heidorn MW; Humrich JY; Johanson L; Aherrahrou R; Reinberger T; Schulz A; Ten Cate V; Robles AP; Koeck T; Rapp S; Lange T; Brachaczek L; Luebber F; Erdmann J; Heidecke H; Schulze-Forster K; Dechend R; Lackner KJ; Pfeiffer N; Ghaemi Kerahrodi J; Tüscher O; Schwarting A; Strauch K; Münzel T; Prochaska JH; Riemekasten G; Wild PS
    Eur Heart J; 2023 Dec; 44(47):4935-4949. PubMed ID: 37941454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emerging clinical phenotypes associated with anti-cytokine autoantibodies.
    Vincent T; Plawecki M; Goulabchand R; Guilpain P; Eliaou JF
    Autoimmun Rev; 2015 Jun; 14(6):528-35. PubMed ID: 25633324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunoadsorption of Agonistic Autoantibodies Against α1-Adrenergic Receptors in Patients With Mild to Moderate Dementia.
    Hempel P; Heinig B; Jerosch C; Decius I; Karczewski P; Kassner U; Kunze R; Steinhagen-Thiessen E; Bimmler M
    Ther Apher Dial; 2016 Oct; 20(5):523-529. PubMed ID: 27096216
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of autoantibodies against β1-adrenoceptor aggravates the kidney injury in rats.
    Zuo L; Zhao R; Wang L; Lv DC; Shi SH; Wang K; Li X; Lv TT; Zhao RR; Liu HR
    Sheng Li Xue Bao; 2014 Apr; 66(2):175-85. PubMed ID: 24777408
    [TBL] [Abstract][Full Text] [Related]  

  • 17. COVID-19, G protein-coupled receptor, and renin-angiotensin system autoantibodies: Systematic review and meta-analysis.
    Akbari A; Hadizadeh A; Islampanah M; Salavati Nik E; Atkin SL; Sahebkar A
    Autoimmun Rev; 2023 Sep; 22(9):103402. PubMed ID: 37490975
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies in patients with post-COVID syndrome: a possible link with severity?
    Ceccarini MR; Bonetti G; Medori MC; Dhuli K; Tezzele S; Micheletti C; Maltese PE; Cecchin S; Donato K; Fioretti F; Calzoni A; Praderio A; De Angelis MG; Nodari S; Arabia G; Lorusso L; Beccari T; Bertelli M
    Eur Rev Med Pharmacol Sci; 2023 Dec; 27(6 Suppl):48-56. PubMed ID: 38112956
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pro-arrhythmic action of autoantibodies against the second extracellular loop of β1-adrenoceptor and its underlying molecular mechanisms.
    Zuo L; Du Y; Ma J; Wang K; Zhao Y; Bai F; Wu B; Ma X; Liu H
    Int J Cardiol; 2015 Nov; 198():251-8. PubMed ID: 26241168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aptamer binding and neutralization of β1-adrenoceptor autoantibodies: basics and a vision of its future in cardiomyopathy treatment.
    Haberland A; Wallukat G; Schimke I
    Trends Cardiovasc Med; 2011 Aug; 21(6):177-82. PubMed ID: 22814426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.